Pyruvate kinase deficiency in children

Background Pyruvate kinase deficiency (PKD) is a rare, autosomal recessive red blood cell enzyme disorder, which leads to lifelong hemolytic anemia and associated complications from the disease and its management. Methods An international, multicenter registry enrolled 124 individuals younger than 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2021-09, Vol.68 (9), p.e29148-n/a
Hauptverfasser: Chonat, Satheesh, Eber, Stefan W., Holzhauer, Susanne, Kollmar, Nina, Morton, D. Holmes, Glader, Bertil, Neufeld, Ellis J., Yaish, Hassan M., Rothman, Jennifer A., Sharma, Mukta, Ravindranath, Yaddanapudi, Wang, Heng, Breakey, Vicky R., Sheth, Sujit, Bradeen, Heather A., Al‐Sayegh, Hasan, London, Wendy B., Grace, Rachael F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Pyruvate kinase deficiency (PKD) is a rare, autosomal recessive red blood cell enzyme disorder, which leads to lifelong hemolytic anemia and associated complications from the disease and its management. Methods An international, multicenter registry enrolled 124 individuals younger than 18 years old with molecularly confirmed PKD from 29 centers. Retrospective and prospective clinical data were collected. Results There was a wide range in the age at diagnosis from 0 to 16 years. Presentation in the newborn period ranged from asymptomatic to neonatal jaundice to fulminant presentations of fetal distress, myocardial depression, and/or liver failure. Children 12 to
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.29148